BMT CTN Protocol 1301 (PROGRESS II)

A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions
for Prevention of Graft-versus Host-Disease.

Below are protocol-related documents, which may be periodically updated.

            Protocol Co-Chair: Leo Luznik, MD

            Protocol Co-Chair: Miguel-Angel Perales, MD (212-639-8682)

            Protocol Co-Chair: Marcelo Pasquini, MD (414-805-0700)

            Protocol Coordinator: Kristy Applegate (301-251-1161)

            Medical Monitor: Tamila Kindwall-Keller, MD (434-982-6406)

The BMT CTN is committed to including widespread transplant community participation in these trials. However, affiliate center applications are not currently being accepted for this study.